Presynaptic regulation of neurotransmitter release in hypertension
- PMID: 1680586
- DOI: 10.1111/j.1440-1681.1991.tb01478.x
Presynaptic regulation of neurotransmitter release in hypertension
Abstract
1. The present review discusses evidence in support of the concept that alterations in sympathetic neurotransmitter release might contribute to the pathogenesis of hypertension. 2. Studies suggest that changes in sympathetic nervous activity in both the central and peripheral nervous systems participate in blood pressure control. 3. In the periphery increased release of norepinephrine from vascular adrenergic neurons might lead to the enhanced vasoconstrictor responses and thus to an elevation in systemic blood pressure. 4. The amount of neurotransmitter release from sympathetic nerve endings can be regulated by autoregulatory systems by presynaptic receptors located on nerve terminals. 5. It has been proposed that alterations to sympathetic nervous activity of hypertension might be partially due to abnormalities in presynaptic modulation of neurotransmitter release in central and peripheral tissues. 6. This article summarizes the results of studies to evaluate presynaptic receptor functions and sympathetic neurotransmitter release in hypertension.
Similar articles
-
Renin-Angiotensin system and sympathetic neurotransmitter release in the central nervous system of hypertension.Int J Hypertens. 2012;2012:474870. doi: 10.1155/2012/474870. Epub 2012 Nov 21. Int J Hypertens. 2012. PMID: 23227311 Free PMC article.
-
Minireview. Presynaptic receptors and alterations in norepinephrine release in spontaneously hypertensive rats.Life Sci. 1983 Oct 17;33(16):1527-42. doi: 10.1016/0024-3205(83)90693-8. Life Sci. 1983. PMID: 6314074 Review.
-
Presynaptic regulation of the release of catecholamines.Pharmacol Rev. 1980 Dec;32(4):337-62. Pharmacol Rev. 1980. PMID: 6267618
-
Presynaptic modulation of sympathetic neurotransmitter release by modulators of cyclic 3',5'-guanosine monophosphate in canine vascular smooth muscle.Ann N Y Acad Sci. 1990;604:305-22. doi: 10.1111/j.1749-6632.1990.tb32002.x. Ann N Y Acad Sci. 1990. PMID: 1977353 Review. No abstract available.
-
Sympathetic nerve activity and neurotransmitter release in humans: translation from pathophysiology into clinical practice.Acta Physiol Scand. 2003 Mar;177(3):275-84. doi: 10.1046/j.1365-201X.2003.01089.x. Acta Physiol Scand. 2003. PMID: 12608997 Review.
Cited by
-
Impact of Chromogranin A deficiency on catecholamine storage, catecholamine granule morphology and chromaffin cell energy metabolism in vivo.Cell Tissue Res. 2016 Mar;363(3):693-712. doi: 10.1007/s00441-015-2316-3. Epub 2015 Nov 16. Cell Tissue Res. 2016. PMID: 26572539 Free PMC article.
-
Renin-Angiotensin system and sympathetic neurotransmitter release in the central nervous system of hypertension.Int J Hypertens. 2012;2012:474870. doi: 10.1155/2012/474870. Epub 2012 Nov 21. Int J Hypertens. 2012. PMID: 23227311 Free PMC article.
-
Royal jelly causes hypotension and vasodilation induced by increasing nitric oxide production.Food Sci Nutr. 2019 Feb 17;7(4):1361-1370. doi: 10.1002/fsn3.970. eCollection 2019 Apr. Food Sci Nutr. 2019. PMID: 31024709 Free PMC article.
-
Effects of ethanol on brain monoamine content of spontaneously hypertensive rats (SHR).Neurochem Res. 1993 Dec;18(12):1293-7. doi: 10.1007/BF00975050. Neurochem Res. 1993. PMID: 7505892
-
The Newly Synthesized Pyrazole Derivative 5-(1-(3 Fluorophenyl)-1H-Pyrazol-4-yl)-2H-Tetrazole Reduces Blood Pressure of Spontaneously Hypertensive Rats via NO/cGMO Pathway.Front Physiol. 2018 Aug 7;9:1073. doi: 10.3389/fphys.2018.01073. eCollection 2018. Front Physiol. 2018. PMID: 30131720 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical